Explore Brainstorm Cell stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BCLI. Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More ...
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Bob Dagher to Executive Vice ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback